SEC Form 4 · accession 0000899243-17-004827
Mylan N.V. · MYL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph C Maroon M.D.
Director
Period of report
Feb 17, 2017
Accepted (ET)
Feb 21, 2017 · 7:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001623613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Feb 17, 2017 | M | 3,567 | $0.00 | A | 25,603 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | $0.00 | Feb 17, 2017 | M | 3,567 | D | — | — | Ordinary Shares | 3,567 | 0 | D |
Explanation of responses
- F1Each restricted stock unit (RSU) represents the right to receive one ordinary share of Mylan N.V. These RSUs vested in full on February 17, 2017.